tiprankstipranks
Wolfe starts Merck at Peer Perform, notes competitive overhangs
The Fly

Wolfe starts Merck at Peer Perform, notes competitive overhangs

Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is Gardasil’s outlook in China, and while it was hoping that the company’s infant RSV antibody would pivot focus, the full results did little to alleviate concerns. Wolfe added that it would argue Merck is further clouded by competitive overhangs for its pneumococcal vaccine franchise given the ongoing nuclear arms race to increase serotype coverage.

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App